首页> 美国卫生研究院文献>European Heart Journal: Case Reports >The power of optimal medical therapy using angiotensin receptor-neprilysin inhibitor in acute decompensated heart failure sparing a critical patient open-heart surgery with a device therapy: a case report
【2h】

The power of optimal medical therapy using angiotensin receptor-neprilysin inhibitor in acute decompensated heart failure sparing a critical patient open-heart surgery with a device therapy: a case report

机译:使用血管紧张素受体 - 内胚抑制剂在急性失代偿性心力衰竭中的最佳医疗疗法力量用设备疗法制止临界患者露天手术:案例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Timely use of Sacubitril/Valsartan has the potential to significantly improve cardiac function and dramatically reduce secondary mitral regurgitation (MR) severity even in patients presenting with acute decompensated heart failure (HF), not only in compensated chronic HF patients. The outstanding impact of echocardiography is obvious in monitoring improvement of cardiac function and MR severity in patients with HF with reduced ejection fraction (HFrEF).
机译:及时使用Sacubitril / Valsartan具有显着改善心脏功能的潜力,并且即使在患有急性失代偿的心力衰竭(HF)的患者中,均显着降低二次二尖瓣流动(MR)严重程度,不仅在补偿的慢性HF患者中。超声心动图的出现影响是显而易见的,以监测HF减少射血分数(HFREF)的HF患者的心功能和MR严重程度。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号